Penn gene therapy spinout taking on rare retinal diseases launches with $19M in seed funding
September 22, 2021 at 11:43 AM EDT
The company aims to commercialize the research of Penn Medicine gene therapy pioneer Dr. Jean Bennett.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|